Every finding on record at Amedisys Arkansas, LLC

On 5/30/2023 at 1:00 PM, an entrance conference was conducted with Agency Representatives. The Agency was informed the purpose of the visit was to conduct a Recertification Survey for compliance with the conditions of Participation for Home Health. On 6/01/23 at 10:45 AM, an exit conference was conducted with Agency Representatives. Preliminary findings were discussed. On 6/15/23 ay 3:20 PM, additional information was requested. Findings as follows:

A review of all current medications CFR(s): 484.55(c)(5) A review of all medications the patient is currently using in order to identify any potential adverse effects and drug reactions, including ineffective drug therapy, significant side effects, significant drug interactions, duplicate drug therapy, and noncompliance with drug therapy. This ELEMENT is not met as evidenced by: Based on clinical review and staff interviews, it was determined the Skilled Nurse (SN) failed to include Oxygen (O2) during the review of the patients medications in 2 (#2, #3) of 10 records reviewed (#1-#10). This failed practice by the SN posed a risk of potential harm for patients on census receiving O2 therapy by inhibiting the Nurse and Physician's ability to make informed decisions regarding the patients medication regimen related to potential adverse effects, drug reactions, significant side effects or significant drug interactions. Review of Clinical Record #2 revealed the following: a) Document titled Client Medication Report dated 4/11/23-6/9/23 with oxygen listed but highlighted in blue. The EMR (electronic medical record) program used by the agency highlights medications not checked for interactions against all other medications in the color blue. b) No evidence in EMR #2 to indicate a manual check was completed. 2. Review of Clinical Record #3 revealed the following: a) Document titled Client Medication Report dated 4/01/23-5/30/23 with oxygen listed but highlighted in blue. The EMR program used by the agency highlights in blue the medications not checked for interactions against all other medications listed. b) No evidence of documentation in EMR #3 to indicate a manual check was completed.